Aim Immunotech Inc (AIM)

$0.09 -0.02 (-19.37%)
Market Cap 6.86M
Revenue (ttm) 170,000.00
Net Income (ttm) -17.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10,188.24%
Debt to Equity Ratio 0.00
Volume 2,305,500
Avg Vol 1,052,822
Day's Range N/A - N/A
Shares Out 72.29M
Stochastic %K 42%
Beta 0.76
Analysts Strong Sell
Price Target $2.75

Latest News on AIM

No data available.